57 related articles for article (PubMed ID: 38436112)
1. Construction of diagnostic models for the progression of hepatocellular carcinoma using machine learning.
Jiang X; Zhou R; Jiang F; Yan Y; Zhang Z; Wang J
Front Oncol; 2024; 14():1401496. PubMed ID: 38812780
[TBL] [Abstract][Full Text] [Related]
2. Erratum: HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
Hepatology; 2024 Apr; 79(4):E127. PubMed ID: 38498370
[No Abstract] [Full Text] [Related]
3. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).
Reichl P; Mikulits W
Oncol Rep; 2016 Aug; 36(2):613-25. PubMed ID: 27278244
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
5. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
[No Abstract] [Full Text] [Related]
6. A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma.
Attallah AM; El-Far M; Abdel Malak CA; Farid K; Omran MM; Yahya RS; Saad EA; Albannan MS; Attallah AA; El Basuni MA; Ali IS; Abed SB; El Naggar MA
Ann Hepatol; 2015; 14(6):869-80. PubMed ID: 26436359
[TBL] [Abstract][Full Text] [Related]
7. HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma.
Attallah AM; El-Far M; Malak CA; Omran MM; Shiha GE; Farid K; Barakat LA; Albannan MS; Attallah AA; Abdelrazek MA; Elbendary MS; Sabry R; Hamoda GA; Elshemy MM; Ragab AA; Foda BM; Abdallah SO
Tumour Biol; 2015 Sep; 36(10):7667-74. PubMed ID: 25929809
[TBL] [Abstract][Full Text] [Related]
8. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma.
Attallah AM; El-Far M; Abdel Malak CA; Zahran F; Farid K; Omran MM; Zagloul H; El-Deen MS
Clin Chim Acta; 2011 Nov; 412(23-24):2310-5. PubMed ID: 21924253
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification and early detection biomarkers for precision HCC screening.
Lee YT; Fujiwara N; Yang JD; Hoshida Y
Hepatology; 2023 Jul; 78(1):319-362. PubMed ID: 36082510
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level.
Wei X; Su R; Yang M; Pan B; Lu J; Lin H; Shu W; Wang R; Xu X
Transl Oncol; 2022 Jun; 20():101422. PubMed ID: 35430532
[TBL] [Abstract][Full Text] [Related]
13. The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
Hu X; Chen R; Wei Q; Xu X
Int J Biol Sci; 2022; 18(2):536-551. PubMed ID: 35002508
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside.
Guan MC; Wang MD; Liu SY; Ouyang W; Liang L; Pawlik TM; Xu QR; Huang DS; Shen F; Zhu H; Yang T
World J Gastrointest Oncol; 2021 Apr; 13(4):197-215. PubMed ID: 33889272
[TBL] [Abstract][Full Text] [Related]
15. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
